Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Wirth

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Immunology|July 28, 2018
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor StudyLisa Lohmann, Claudia Janoschka, Andreas Schulte-Mecklenbeck, et al.
Critical Care (London, England)|August 15, 2025
DPP4 inhibition curbs systemic inflammationKatharina E M Hellenthal, Sebastian Kintrup, Timo Wirth, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2013
Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4Dirk Foell, Helmut Wittkowski, Christoph Kessel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2021
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple SclerosisMelanie Eschborn, Marc Pawlitzki, Timo Wirth, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Immune signatures of prodromal multiple sclerosis in monozygotic twinsLisa Ann Gerdes, Claudia Janoschka, Maria Eveslage, et al.
Brain : a Journal of Neurology|April 26, 2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunityAnn-Katrin Fleck, Stephanie Hucke, Flavio Teipel, et al.
Nature Communications|May 15, 2024
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentI-Na Lu, Phyllis Fung-Yi Cheung, Michael Heming, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Science Translational Medicine|May 3, 2019
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effectsLuisa Klotz, Melanie Eschborn, Maren Lindner, et al.
Science Translational Medicine|March 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectoriesCatharina C Gross, Andreas Schulte-Mecklenbeck, Olga V Steinberg, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Immunology|July 28, 2018
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor StudyLisa Lohmann, Claudia Janoschka, Andreas Schulte-Mecklenbeck, et al.
Critical Care (London, England)|August 15, 2025
DPP4 inhibition curbs systemic inflammationKatharina E M Hellenthal, Sebastian Kintrup, Timo Wirth, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2013
Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4Dirk Foell, Helmut Wittkowski, Christoph Kessel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2021
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple SclerosisMelanie Eschborn, Marc Pawlitzki, Timo Wirth, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Immune signatures of prodromal multiple sclerosis in monozygotic twinsLisa Ann Gerdes, Claudia Janoschka, Maria Eveslage, et al.
Brain : a Journal of Neurology|April 26, 2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunityAnn-Katrin Fleck, Stephanie Hucke, Flavio Teipel, et al.
Nature Communications|May 15, 2024
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentI-Na Lu, Phyllis Fung-Yi Cheung, Michael Heming, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Science Translational Medicine|May 3, 2019
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effectsLuisa Klotz, Melanie Eschborn, Maren Lindner, et al.
Science Translational Medicine|March 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectoriesCatharina C Gross, Andreas Schulte-Mecklenbeck, Olga V Steinberg, et al.
Pageof 3